Chemoinformaics analysis of 2,3,5,5-TETRAMETHYL-4-METHYLENE-2-CYCLOPENTEN-1-ONE
| Molecular Weight | 138.21 | nRot | 0 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 6 |
| Exact Molecular Weight | 138.104 | nRing | 1 |
| Solubility: LogS | -2.229 | nHRing | 0 |
| Solubility: LogP | 2.424 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.1671 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.502 |
| Synth | 3.051 |
| Natural Product Likeliness | 1.572 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.251 |
| Pgp-sub | 0.005 |
| HIA | 0.009 |
| CACO-2 | -4.57 |
| MDCK | 0.0000287 |
| BBB | 0.173 |
| PPB | 0.670879 |
| VDSS | 1.371 |
| FU | 0.541664 |
| CYP1A2-inh | 0.473 |
| CYP1A2-sub | 0.872 |
| CYP2c19-inh | 0.462 |
| CYP2c19-sub | 0.901 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.708 |
| CYP2d6-inh | 0.191 |
| CYP2d6-sub | 0.632 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.351 |
| CL | 5.49 |
| T12 | 0.476 |
| hERG | 0.009 |
| Ames | 0.009 |
| ROA | 0.131 |
| SkinSen | 0.192 |
| Carcinogencity | 0.06 |
| EI | 0.827 |
| Respiratory | 0.352 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.943615 |